LEADER 01514nam0 22003493i 450 
001 VAN00289450
005 20251215082433.992
017 70$2N$a9783319396644
100   $a20250318d2016       |0itac50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
181   $ai$b   e  
182   $ab
183   $acr
200 1 $aInterleukin-27: Biological Properties and Clinical Application$fMarek Jankowski, Tomasz Wandtke
210   $aCham$cSpringer$d2016
215   $aVI, 86 p.$cill.$d24 cm
410  1$1001VAN00282574$12001 $aSpringerBriefs in Immunology$1210  $aCham$cSpringer$d2013-
620   $aCH$dCham$3VANL001889
676   $a616.079$cImmunologia$v22
700  1$aJankowski$bMarek$3VANV244401$01064615
701  1$aWandtke$bTomasz$3VANV244402$01790407
712   $aSpringer <editore>$3VANV108073$4650
801   $aIT$bSOL$c20251219$gRICA
856 4 $uhttps://link.springer.com/book/10.1007/978-3-319-39664-4$zE-book - Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$1IT-CE0101$2VAN17
912   $fN
912   $aVAN00289450
950   $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$d17CONS      e-book                  177         $e17BIB177/286   286     20250318            
996   $aInterleukin-27: Biological Properties and Clinical Application$94326863
997   $aUNICAMPANIA